# CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium

> **NCT01808729** · — · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 34 (actual)

## Conditions studied

- Fibromuscular Dysplasia
- Early Onset CAD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01808729
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808729, "CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01808729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*